OKYO Pharma Limited

OKYO Pharma Limitedverified

OKYO

Price:

$1.065

Market Cap:

$36.09M

OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead product includes OK-101 for the treatment of dry eye disease. The company is also developing OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic ocular pain. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.[Read more]

Industry

Biotechnology

IPO Date

2022-05-17

Stock Exchange

NASDAQ

Ticker

OKYO

The PE Ratio as of December 2024 (TTM) for OKYO Pharma Limited (OKYO) is -1.87

According to OKYO Pharma Limited’s latest financial reports and current stock price. The company's current PE Ratio is -1.87. This represents a change of -95.67% compared to the average of -43.18 of the last 4 quarters.

OKYO Pharma Limited (OKYO) Historical PE Ratio (quarterly & annually)

How has OKYO PE Ratio performed in the past?

The mean historical PE Ratio of OKYO Pharma Limited over the last ten years is -1332.27. The current -1.87 PE Ratio has changed -85.96% with respect to the historical average. Over the past ten years (40 quarters), OKYO's PE Ratio was at its highest in in the December 2019 quarter at 166.94. The PE Ratio was at its lowest in in the March 2020 quarter at -1307.50.

Quarterly (TTM)
Annual

Average

-1332.27

Median

-689.46

Minimum

-5703.33

Maximum

-2.82

OKYO Pharma Limited (OKYO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of OKYO Pharma Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 90.89%

Maximum Annual PE Ratio = -2.82

Minimum Annual Increase = -99.57%

Minimum Annual PE Ratio = -5703.33

Quarterly (TTM)
Annual
YearPE RatioChange
2024-2563.6990.89%
2023-2.82-99.57%
2022-652.68-10.13%
2021-726.23-48.04%
2020-1397.80268.36%
2019-379.47673.89%
2018-49.03-99.14%
2017-5703.33239.02%
2016-1682.32917.27%
2015-165.38111.43%

OKYO Pharma Limited (OKYO) Average PE Ratio

How has OKYO PE Ratio performed in the past?

The current PE Ratio of OKYO Pharma Limited (OKYO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-1073.06

5-year avg

-1068.64

10-year avg

-1332.27

OKYO Pharma Limited (OKYO) PE Ratio vs. Peers

How is OKYO’s PE Ratio compared to its peers?

OKYO Pharma Limited’s PE Ratio is less than Bionomics Limited (-0.30), greater than Candel Therapeutics, Inc. (-5.40), greater than Anebulo Pharmaceuticals, Inc. (-5.30), less than Cingulate Inc. (-0.00), less than Unicycive Therapeutics, Inc. (0), greater than Quoin Pharmaceuticals, Ltd. (-2.06), less than Cardio Diagnostics Holdings, Inc. (-0.28), greater than Virax Biolabs Group Limited (-2.99), less than PaxMedica, Inc. Common Stock (-0.57), less than Senti Biosciences, Inc. (-0.03), less than ZIVO Bioscience, Inc. (-0.27), greater than Cadrenal Therapeutics, Inc. Common Stock (-5.50), greater than Foghorn Therapeutics Inc. (-2.14), greater than Clearmind Medicine Inc. (-3.45), less than Hillstream BioPharma, Inc. (-0.84), less than Coeptis Therapeutics, Inc. (-0.99), less than Magenta Therapeutics, Inc. (-0.49), less than null (-0.15),

Build a custom stock screener for OKYO Pharma Limited (OKYO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like OKYO Pharma Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

OKYO Pharma Limited (OKYO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like OKYO Pharma Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is OKYO Pharma Limited's PE Ratio?

How is the PE Ratio calculated for OKYO Pharma Limited (OKYO)?

What is the highest PE Ratio for OKYO Pharma Limited (OKYO)?

What is the 3-year average PE Ratio for OKYO Pharma Limited (OKYO)?

What is the 5-year average PE Ratio for OKYO Pharma Limited (OKYO)?

How does the current PE Ratio for OKYO Pharma Limited (OKYO) compare to its historical average?